Option chain shows key data for Jervois Glb's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Jervois Glb.

Jervois Glb (OTC:JRVMF) Stock, Option Chain

Jervois Global Ltd is a cobalt company with nickel and copper exposure, refinery assets, and growth opportunities. The company's project includes Idaho Cobalt, Sao Miguel Paulista Refinery, Nico Young, and other non-core assets. The company's operating segment includes Australia, Brazil, Finland, the United States, and Others. The company generates the majority of its revenue from the Finland segment, which includes the cobalt refining and specialty products business located in Kokkola, Finland.

Penny Stocks

Small Cap

JRVMF

TSXV:JRV

One World Lithium Engages Two New Consultants

News

Intraday Update

Markets

Movers

Trading Ideas

AAXN

ACEL

ADBE

ADCOF

AEHR

AIQUY

AJRD

ALSWF

AMAT

AMRC

AMXEF

ANSS

APEMY

ARCAY

ARCVF

ARES

ARNC

ASMLF

ASTE

AVLR

AVXL

BAESY

BCLI

BESIY

BFAM

BILI

BILL

BRLXF

BTAI

BWXT

BXMT

CALX

CCYC

CDNS

CNSWF

CRMT

CTAS

CYTK

DAVA

DOCU

DOOO

DRUNF

ENTG

EQIX

ESPR

EXLS

EXPGF

EXPO

FAST

FCPT

FLIR

FZRO

GASE

GLIBA

GNRC

GRRB

HENC

HIMX

Hannover Ruckversicherungs Registered shares 

HVRRY

ICAD

Stocks That Hit 52-Week Highs On Thursday

JERVOIS GLOBAL LIMITED by Jervois Global Limited

Jervois Global Ltd

Wedbush analyst Daniel Ives maintains Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) with a Outperform and raises the price target from $515 to $550.

Price Target

Analyst Ratings

TSLA

Wedbush Maintains Outperform on Tesla, Raises Price Target to $550

Guggenheim analyst Michael Schmidt reiterates Century Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPSC#NASDAQ">IPSC</a>) from Buy to Buy.

Reiteration

IPSC

Guggenheim Reiterates Buy on Century Therapeuticsto Buy

Barclays analyst Dan Levy maintains Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) with a Equal-Weight and raises the price target from $13 to $14.

RIVN

Barclays Maintains Equal-Weight on Rivian Automotive, Raises Price Target to $14

Rumors

CTOS

Watching Custom Truck One Source; Traders Circulate Zacks Under $10 Newsletter Picks Stock

IPOs

MCTR

CTRL Group IPO Shares Open For Trade At $4/Share; IPO Priced At $4/Share

The Travelers Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) shares are trading <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43123185/travelers-reports-exceptional-fourth-quarter-and-full-year-results" rel="noreferrer noopener">higher in the premarket session on Wednesday.</a>
The company reported fourth-quarter adjusted earnings per share of $9.15, beating the street view of $6.65. Quarterly sales of $12.008 billion (+10%) outpaced the analyst consensus estimate of $10.754 billion.
&#8220;We are very pleased to report record core income for the quarter of $2.1 billion driven by strong growth in earned premiums and excellent profitability,&#8221; said Alan Schnitzer, chairman and CEO.
Net written premiums jumped 7% to $10.742 billion in the quarter under review. Core income jumped 30% year over year to $2.126 billion.
The company stated that, due to its strong balance sheet and results, they were able to grow adjusted book value per share by 13% to $139.04, after making significant investments and returning over $2.1 billion of excess capital to shareholders through dividends and share repurchases.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/43122112/us-stocks-likely-to-open-higher-as-president-trump-announces-500-billion-ai-project-oracle-netflix-nvidia-among-stocks-in-focus" rel="noreferrer noopener">US Stocks Likely To Open Higher As President Trump Announces $500 Billion AI Project: Oracle, Netflix, Nvidia Among Top Stocks To Watch</a>
&#8220;The improvement in the combined ratio was driven by very strong underlying profitability and higher net favorable prior year reserve development. Earned premiums and underwriting margins were strong in all three segments,&#8221; Schnitzer added.
The company repurchased 1.0 million shares during the fourth quarter at an average price of $255.41 per share for a total cost of $252 million.&nbsp;
The company declared a regular quarterly dividend of $1.05 per share. The dividend is payable March 31, to shareholders of record at the close of business on March 10.
Price Action: TRV shares are trading higher by 5.24% to $251.70&nbsp;premarket at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43118541/bitcoin-ethereum-dogecoin-rally-amid-secs-plans-to-establish-crypto-regulations-top-trader-issues-bold-3000-target-for-btc-this-cycle" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum Rally Amid SEC's Plans To Establish Crypto Regulations: Top Trader Issues $300,000 Target For BTC This Cycle</a></li>
</ul>

Equities

General

Travelers Reports 10% Sales Growth In Q4, Driven by Strong Performance in Earned Premiums

United Airlines Exec Says Expect Q1 To Be Our Best Atlantic Financial Results In Co's Q1 History

<a href="https://truthsocial.com/@realDonaldTrump/posts/113872782548137314" title="https://truthsocial.com/@realDonaldTrump/posts/113872782548137314">https://truthsocial.com/@realDonaldTrump/posts/113872782548137314</a>

Macro Economic Events

Global

Economics

UUUU

President Donald J. Trump Posts On Truth "... If we don't make a "deal," and soon, I have no other choice but to put high levels of Taxes, Tariffs, and Sanctions on anything being sold by Russia to the United States, and various other participating countries..."

On Tuesday, Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) announced plans to acquire the da Vinci and Ion distribution businesses in Italy, Spain, Portugal, Malta, San Marino, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g43107335/intuitive-announces-plans-to-establish-direct-presence-in-italy-spain-portugal" rel="noreferrer noopener">and associated territories.</a>
The acquisition, subject to regulatory approvals, will expand Intuitive&#8217;s direct presence in these regions, with the transaction expected to close in 2026.
Intuitive has entered into an agreement with its current distributors, ab medica, Abex, and Excelencia Robotica, to purchase their Intuitive product-related business.
Once the deal is finalized, the acquired businesses will be fully integrated into Intuitive&#8217;s European operations, led by Senior Vice President and General Manager Dirk Barten.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/25/01/43121203/netflix-rises-15-in-wednesday-premarket-as-streaming-giant-hikes-prices-following-record-subscriber-growth" rel="noreferrer noopener">Netflix Rises 15% In Wednesday Premarket As Streaming Giant Hikes Prices Following Record Subscriber Growth</a>
CEO Gary Guthart expressed excitement about the opportunity to bring minimally invasive care to more patients across Europe. He highlighted the importance of having a direct presence in these countries to better understand the unique needs of customers.
&#8220;Having a direct presence in Italy, Spain, Portugal, Malta, and San Marino, and associated territories allows us to deepen our understanding of unique customer needs in these countries,&#8221; Guthart added.
Francesca Cerruti, CEO of ab medica, emphasized their long history of introducing robotic-assisted surgery in Southern Europe.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, ISRG stock has gained over 62% in the past year. Investors can gain exposure to the stock via&nbsp;Spinnaker ETF Series Langar Global HealthTech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LGHT#NYSE">LGHT</a>).
Price Action: ISRG shares are trading higher by 1.03% to $610.33 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/25/01/43118598/warren-buffetts-pilot-co-exits-global-oil-trading-refocuses-on-us-operations-report" target="_blank" rel="noreferrer noopener">Warren Buffett&#8217;s Pilot Co Exits Global Oil Trading, Refocuses On US Operations: Report</a></li>
</ul>
Photo via Shutterstock.

Health Care

ISRG

LGHT

Intuitive Surgical Expands Direct Reach: Plans Acquiring Key European da Vinci And Ion Distribution Businesses

Barclays analyst Dan Levy maintains Mobileye Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) with a Overweight and raises the price target from $18 to $22.

MBLY

Barclays Maintains Overweight on Mobileye Global, Raises Price Target to $22

Guggenheim analyst Michael Schmidt reiterates Exelixis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) from Buy to Buy.

EXEL

Guggenheim Reiterates Buy on Exelixisto Buy

<a href="https://www.theinformation.com/briefings/openai-preps-operator-release-for-this-week" title="https://www.theinformation.com/briefings/openai-preps-operator-release-for-this-week">https://www.theinformation.com/briefings/openai-preps-operator-release-for-this-week</a>

MSFT

'OpenAI Is Preparing To Release A New ChatGPT Feature This Week That Will Automate Complex Tasks Typically Done Through The Web Browser, Such As Making Restaurant Reservations Or Planning Trips, According To A Person With Direct Knowledge Of The Plans' - The Information

Warren Buffett, one of the most famous investors ever, has long admired Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and thinks it&#8217;s one of the best companies in the world. He once made a bold claim that perfectly illustrates how much people love their iPhones.
In 2023, Buffett <a href="https://x.com/SquawkCNBC/status/1646136625355710464">told</a> CNBC&#8217;s Squawk Box, "If you're an Apple user and somebody offers you $10,000, but the only proviso is they'll take away your iPhone and you'll never be able to buy another, you're not going to take it." He believes people value their iPhones so much that even $10,000 wouldn't convince them to give them up forever.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&quot; <a href="https://twitter.com/tim_cook?ref_src=twsrc%5Etfw">@tim_cook</a> is one of the classiest CEOs and he understands the business. Tim Cook has managed that company in an extraordinary way,&quot; says Warren Buffett on <a href="https://twitter.com/search?q=%24AAPL&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$AAPL</a>. &quot;It&#39;s a wonderful business so we own a lot of it.&quot; <a href="https://t.co/1lVUNIfgnT">pic.twitter.com/1lVUNIfgnT</a>
&mdash; Squawk Box (@SquawkCNBC) <a href="https://twitter.com/SquawkCNBC/status/1646136625355710464?ref_src=twsrc%5Etfw">April 12, 2023</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>According to Juniper Research, the total value of B2B cross-border payments stored on the blockchain is projected to exceed $4.4 trillion — <a href="https://www.benzinga.com/money/web3-enabler-future-of-enterprise-transactions">Join the first company to bring blockchain payments to Salesforce early with just $100.</a></li>
</ul>
<h2 class="wp-block-heading">Apple's Unmatched Loyalty</h2>
Buffett says Apple is special because it creates products that people truly enjoy. The iPhone is not just a phone – it's an experience many users see as part of their daily lives. Even though there are other phones with cool features – like better cameras, folding screens or advanced AI – none give the same smooth and simple experience as iPhones.
It's not just the usability. Owning an iPhone makes people feel connected to a larger community. Giving up an iPhone, as Buffett suggested, means stepping out of a social circle and giving up the ecosystem that so many users find irreplaceable.
On the other hand, he said, "If they tell you if you buy another Ford Motor car, they'll give you $10,000 not to do that, you'll take the $10,000 and buy a Chevy instead."&nbsp;
See Also: With 100+ historic trademark victories, this company holds IP for some of the highest-grossing characters in history. Now, they've propelled these icons into the future using next-gen patented AR, VR, and AI technology. <a href="https://www.benzinga.com/money/elf-labs-1">There&#8217;s now a limited window for investors to claim shares at just $2/share with $980 minimum—but the clock is ticking.</a>
<h2 class="wp-block-heading">A Changing Landscape</h2>
Despite Apple's stronghold on customer loyalty, the company has faced recent challenges. In 2024, <a href="https://www.benzinga.com/trading-ideas/movers/25/01/43042851/apple-shares-dip-as-iphone-sales-in-china-decline-sharply-in-2024-whats-going-on">iPhone sales in China dropped by 17%</a>, marking the biggest annual sales drop Apple has seen in the country. It even lost its market leadership to local competitors like Huawei and Vivo. The broader Chinese smartphone market grew 4% during the same period, showing Apple's struggle to keep up with innovative, domestically produced alternatives.
Apple offered rare discounts on its iPhone 16 models in China to fight back. However, competition from foldable and AI-powered phones made by other brands continues to challenge Apple.
Trending: <a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a>
<h2 class="wp-block-heading">Buffett's Evolving Strategy</h2>
Interestingly, Buffett's actions regarding Apple have raised eyebrows. Berkshire Hathaway, the investment firm he leads, recently <a href="https://www.benzinga.com/markets/equities/24/11/41993666/warren-buffetts-berkshire-hathaway-slashes-apple-bofa-holdings-adds-dominos-pizza-in-q3">reduced its Apple stake by 25%</a>, leaving it with 300 million shares. While Apple still accounts for 26% of Berkshire's portfolio, the sale reflects Buffett's commitment to his value investing principles – he's always looking for quality investments at a fair price.
This sale helped <a href="https://www.benzinga.com/markets/24/12/42668097/warren-buffett-heads-into-2025-with-325-billion-cash-pile-his-largest-in-over-three-decades-expert-says-it-will-provide-an-opportunity-for-the-successors-to-make-their-own-mark">Berkshire build up $325 billion in cash</a>, the most it's ever had. Some experts think Buffett is preparing for a possible market downturn or making things easier for the next leader of Berkshire Hathaway.
Read Next:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>Built on the trusted network of Fortune 500 companies, <a href="https://www.benzinga.com/money/web3-enabler-the-most-boring-blockchain-company-partners-with-salesforce">this blockchain company partners with Salesforce to uproot lengthy and expensive B2B transactions, and you can invest with just $100.</a></li>
</ul>

AAPL

Warren Buffett Once Claimed iPhones Are So Great That No One Would Take $10,000 To Stop Buying Them

In the current market session, Huntington Bancshares Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBAN#NASDAQ">HBAN</a>) stock price is at $16.86, after a 1.43% drop. However, over the past month, the company's stock spiked by 2.03%, and in the past year, by 30.26%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1737560712_0.png" alt="Past Year Chart" />

<h3>Huntington Bancshares P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 17.42 in the Banks industry, Huntington Bancshares Inc. has a lower P/E ratio of 14.02. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1737560712_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

HBAN

Price Over Earnings Overview: Huntington Bancshares

PTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTC#NASDAQ">PTC</a>) has outperformed the market over the past 5 years by 4.37% on an annualized basis producing an average annual return of 17.53%. Currently, PTC has a market capitalization of $22.61 billion. 
Buying $100 In PTC: If an investor had bought $100 of PTC stock 5 years ago, it would be worth $224.86 today based on a price of $188.19 for PTC at the time of writing.
<h3>PTC's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737560709_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning PTC Stock In The Last 5 Years

Barclays analyst Dan Levy maintains Lear (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEA#NYSE">LEA</a>) with a Equal-Weight and lowers the price target from $120 to $115.

Barclays Maintains Equal-Weight on Lear, Lowers Price Target to $115

United Airlines CEO Says International Environment Is Going To Be Far Stronger For Longer; Structural Supply Constraints Are Going To Last At Least For The Rest Of This Decade; Wide Body Supply, Both Airframes And Engines, Is Even More Challenged Than Narrow Bodies; Cost Convergence Has Been The Most Impactful At The Big High-Cost Airports In The Country

Guggenheim analyst Howard Ma reiterates Dynatrace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DT#NYSE">DT</a>) from Neutral to Neutral.

Guggenheim Reiterates Neutral on Dynatraceto Neutral

Barclays analyst Dan Levy maintains BorgWarner (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWA#NYSE">BWA</a>) with a Overweight and lowers the price target from $47 to $43.

Barclays Maintains Overweight on BorgWarner, Lowers Price Target to $43

Biotech

SDZNY

TEVA

FDA Adds Boxed Warning About Anaphylaxis With Multiple Sclerosis Medicine Glatiramer Acetate (Copaxone, Glatopa)

Comments

Jervois Glb

Jervois Glb (JRVMF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga